FDA approves new trauma device
Panel recommends Melody Transcatheter Pulmonary Valve
The FDA’s Circulatory System Devices Panel has unanimously recommended the approval of Humanitarian Device Exemption of Medtronic’s Melody Transcatheter Pulmonary Valve. The device is designed for patients with congenital heart defects, status post open heart surgery, who developed right ventricular outflow tract (RVOT) obstruction. The Melody Transcatheter Pulmonary Valve is the first transcatheter heart valve to be approved for commercial use anywhere in the world and the first to be reviewed by an FDA panel.
-
FDA Approves Melody Valve
Medtronic wins advisory panel backing for Melody heart valve
Patient receives the first CryoValve SG heart valve
FDA approves Edwards’ Perimount Magna mitral valve
CardiAQ Valve Technologies To Present Latest In Vivo Results Of Its Transcatheter Mitral Valve Implantation System At TCT 2010
